Sangamo Biosciences (SGMO) has disclosed a new risk, in the Manufacturing category.
Sangamo Biosciences does not face any business risks related to mine safety disclosures, as indicated by the ‘Not applicable’ status in their risk assessment. This suggests that the company is not involved in mining operations or any activities that would require compliance with mine safety regulations. Consequently, mine safety is not a concern for Sangamo Biosciences, and it does not impact their overall risk profile. Investors and stakeholders can be reassured that this specific regulatory issue does not pose any threats to the company’s operations.
Overall, Wall Street has a Moderate Buy consensus rating on SGMO stock based on 3 Buys and 3 Holds.
To learn more about Sangamo Biosciences’ risk factors, click here.
